A recent study showed that monoamine oxidase B (MAOB) is highly expressed in GBM mitochondria, and targeting MAOB resulted in mitochondrial-specific DNA damage and efficacy against GBM in mouse xenograft models (Sharpe et al., 2015). The gene discussed is MAOB; the disease is glioblastoma.